Catalyst Wire Dossier Catalyst Wire Dossier

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy, covering 2016-06-27 to 2016-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma [NA]

See pricing